Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Exscientia Plc EXAI

Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules... see more

Bullboard (NDAQ:EXAI)

View:
Comment by shaker13on Jan 07, 2022 6:28am

RE:Interesting new entrant to the AI PubCo space

BTW Re: V.DM here's a little Due Diligence I can share for any interested in taking a peep: https://traffic.libsyn.com/secure/bellpodcast/Bullseye_Brief_Ep119_Marshall_Gunter.mp3   ...more  
Post by shaker13on Jan 07, 2022 6:20am

Interesting new entrant to the AI PubCo space

I'm comfortable with the size of my position I now have built in : https://www.datametrex.com/ But because of my position and due diligence in V.DM I have now become aware of how huge the AI ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities